{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-006139","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2025-02-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.606818+00:00","generated_at":"2026-05-26T23:02:55.489703+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Amends $20M patent deal to credit R&D costs; raises $710K via stock sales","bullets":["Amends Patent Purchase Agreement; cash payments reduced to $306K from $373K as of Dec 31, 2024.","Issued 155,555 shares at $2.25/share for $350K to accredited investor in private placement.","Received $210K from exercise of 140,000 warrants at $1.50/share on Feb 10.","Received $150K from exercise of 100,000 warrants at $1.50/share on Feb 11.","Series B Preferred converted 216 shares (stated value $237,600) into 105,600 common shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-006139","json":"https://secwatch.observer/filing/0001493152-25-006139.json","markdown":"https://secwatch.observer/filing/0001493152-25-006139.md","text":"https://secwatch.observer/filing/0001493152-25-006139.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000149315225006139/0001493152-25-006139-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000149315225006139/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T23:02:55.489703+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}